可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 王若琦.血管紧张素转换酶抑制剂与血管紧张素II受体拮抗剂联用治疗心力衰竭的研究进展[J].心脏杂志,2007,19(1):102-103.
[2] Warner FJ, Smith AI, Hooper NM,et al. Angiotensinconverting enzyme2: a molecular and cellular perspective[J].Cell Mol Life Sci,2004, 61(21):2704-2713.
[3] Towler P, Staker B, Prasad SG,et al. ACE2 Xray structures reveal a large hingebending motion important for inhibitor binding and catalysis[J].J Biol Chem,2004,279(17): 17996-18007.
[4] Leung PS.The peptide hormone angiotensin II: its new functions in tissues and organs[J].Curr Protein Pept Sci,2004, 5(4): 267-273.
[5] Danilczyk U, Eriksson U, Oudit GY, et al. Physiological roles of angiotensinconverting enzyme 2[J].Cell Mol Life Sci,2004,61(21): 2714-2719.
[6] Yamamoto K, Ohishi M, Katsuya T,et al. Deletion of angiotensinconverting enzyme 2 accelerates pressure overloadinduced cardiac dysfunction by increasing local angiotensin II[J].Hypertension, 2006, 47(4): 718-726.
[7] Huentelman MJ, Grobe JL, Vazquez J,et al. Protection from angiotensin IIinduced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats[J].Exp Physiol, 2005, 90(5): 783-790.
[8] Goulter AB, Goddard MJ, Allen JC, et al. ACE2 gene expression is upregulated in the human failing heart[J].BMC Med, 2004, 2(1): 19.
[9] Kittleson MM, Minhas KM, Irizarry RA,et al.Gene expression analysis of ischemic and nonischemic cardiomyopathy: Shared and distinct genes in the development of heart failure[J]. Physiol Genomics, 2005, 21(3): 299-307.
[10]Burrell LM, Risvanis J, Kubota E,et al.Myocardial infarction increases ACE2 expression in rat and humans[J].Eur Heart J,2005, 26(4): 369-375.
[11]Zhong JC, Huang DY, Yang YM,et al. Upregulation of angiotensinconverting enzyme 2 by alltrans retinoic acid in spontaneously hypertensive rats[J].Hypertension, 2004, 44(6): 907-912.
[12]Keidar S, GamlielLazarovich A, Kaplan M,et al. Mineralocorticoid receptor blocker increases angiotensinconverting enzyme 2 activity in congestive heart failure patients[J].Circ Res, 2005, 97(9): 946-953.
[13]Rella M, Rushworth CA, Guy JL, et al. Structurebased pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors[J].J Chem Inf Model, 2006, 46(2): 708-716.
[14]Huentelman MJ, Zubcevic J, Katovich MJ,et al. Cloning and characterization of a secreted form of angiotensinconverting enzyme 2[J].Regu.Pept,2004, 122(2):61-67.
[15]Danilczyk U, Penninger JM. Angiotensinconverting enzyme II in the heart and the kidney[J].Circ Res, 2006, 98(4): 463-471.